Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Investigation of Buyout by Merck

San Diego, CA -- (SBWIRE) -- 06/16/2014 -- An investigation on behalf of investors, who currently hold shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX), was announced concerning whether the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per shares is unfair to NASDAQ:IDIX stockholders.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.